Pathogenesis of Marburg hemorrhagic fever in cynomolgus macaques.

BACKGROUND Marburg virus (MARV) infection causes a severe and often fatal hemorrhagic disease in primates; however, little is known about the development of MARV hemorrhagic fever. In this study we evaluated the progression of MARV infection in nonhuman primates. METHODS Eighteen cynomolgus monkeys were infected with MARV; blood and tissues were examined sequentially over an 8-day period to investigate disease pathogenesis. RESULTS Disease caused by MARV in cynomolgus macaques was very similar to disease previously described for Ebola virus-infected macaques. Monocytes, macrophages, Kupffer cells, and dendritic cells (DCs) were identified as the initial targets of MARV infection. Bystander lymphocyte apoptosis occurred at early stages in the disease course in intravascular and extravascular locations. The loss of splenic and lymph node DCs or downregulation of dendritic cell-specific intercellular adhesion molecule-3-grabbing non-integrin (DC-SIGN) on DCs as early as day 2 and continuing through day 8 after MARV infection was a prominent finding. Evidence of disseminated intravascular coagulation was noted; however, the degree of fibrin deposition in tissues was less prominent than was reported in Ebola-infected macaques. CONCLUSIONS The sequence of pathogenic events identified in this study provides an understanding of the development of disease processes and also may provide new targets for rational prophylactic and chemotherapeutic interventions.

[1]  Heinz Feldmann,et al.  Filoviridae: Marburg and ebola viruses , 2013 .

[2]  H. Feldmann,et al.  Ebola haemorrhagic fever , 2011, The Lancet.

[3]  M. Lackemeyer,et al.  Aerosol Exposure to the Angola Strain of Marburg Virus Causes Lethal Viral Hemorrhagic Fever in Cynomolgus Macaques , 2010, Veterinary pathology.

[4]  R. Koup,et al.  Vector Choice Determines Immunogenicity and Potency of Genetic Vaccines against Angola Marburg Virus in Nonhuman Primates , 2010, Journal of Virology.

[5]  N. Gallagher,et al.  Imported case of Marburg hemorrhagic fever - Colorado, 2008. , 2009, MMWR. Morbidity and mortality weekly report.

[6]  L. Hensley,et al.  Cellular immune response to Marburg virus infection in cynomolgus macaques. , 2008, Viral immunology.

[7]  D. Swenson,et al.  Monovalent virus-like particle vaccine protects guinea pigs and nonhuman primates against infection with multiple Marburg viruses , 2008, Expert review of vaccines.

[8]  J. Köhl,et al.  Impaired dendritic cell differentiation and maturation in the absence of C3. , 2007, Molecular immunology.

[9]  P. Formenty,et al.  Marburg Virus Angola Infection of Rhesus Macaques: Pathogenesis and Treatment with Recombinant Nematode Anticoagulant Protein c2 , 2007, The Journal of infectious diseases.

[10]  P. Jahrling,et al.  Recombinant human activated protein C for the postexposure treatment of Ebola hemorrhagic fever. , 2007, The Journal of infectious diseases.

[11]  Q. Yao,et al.  C‐reactive protein impairs human CD14+ monocyte‐derived dendritic cell differentiation, maturation and function , 2006, European journal of immunology.

[12]  H. Feldmann,et al.  Cross-Protection against Marburg Virus Strains by Using a Live, Attenuated Recombinant Vaccine , 2006, Journal of Virology.

[13]  Alan Kemp,et al.  Marburg hemorrhagic fever associated with multiple genetic lineages of virus. , 2006, The New England journal of medicine.

[14]  J. A. Comer,et al.  Marburgvirus Genomics and Association with a Large Hemorrhagic Fever Outbreak in Angola , 2006, Journal of Virology.

[15]  Heinz Feldmann,et al.  Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses , 2005, Nature Medicine.

[16]  P. Jahrling,et al.  Pathogenesis of Ebola hemorrhagic fever in cynomolgus macaques: evidence that dendritic cells are early and sustained targets of infection. , 2003, The American journal of pathology.

[17]  P. Jahrling,et al.  Mechanisms underlying coagulation abnormalities in ebola hemorrhagic fever: overexpression of tissue factor in primate monocytes/macrophages is a key event. , 2003, The Journal of infectious diseases.

[18]  A. Schmaljohn,et al.  Characterization of monoclonal antibodies to Marburg virus (strain Musoke) glycoprotein and identification of two protective epitopes. , 2003, Virology.

[19]  J. Smith,et al.  Marburg virus vaccines based upon alphavirus replicons protect guinea pigs and nonhuman primates. , 1998, Virology.

[20]  T. Geisbert,et al.  Marburg hemorrhagic fever: report of a case studied by immunohistochemistry and electron microscopy. , 1998, Ultrastructural pathology.

[21]  K. Johnson,et al.  MARBURG-VIRUS DISEASE IN KENYA , 1982, The Lancet.

[22]  R. Salt,et al.  PERCUTANEOUS LUNG BIOPSY , 1976, The Lancet.

[23]  T. Bothwell,et al.  Outbreake of Marburg virus disease in Johannesburg. , 1975, British medical journal.

[24]  J. Casals,et al.  Marburg Virus Disease , 1972, The Yale Journal of Biology and Medicine.

[25]  D. Simpson,et al.  Marburg virus infection in monkeys. Ultrastructural studies. , 1971, Laboratory investigation; a journal of technical methods and pathology.

[26]  G. Maass,et al.  Experimental Infection of Monkeys with the Marburg Virus , 1971 .

[27]  G. Martini Marburg Virus Disease. Clinical Syndrome , 1971 .

[28]  R. Egbring,et al.  Clinical Manifestations and Mechanism of the Haemorrhagic Diathesis in Marburg Virus Disease , 1971 .

[29]  D. Simpson Marburg agent disease: in monkeys. , 1969, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[30]  D. Simpson,et al.  Vervet monkey disease. Experiment infection of guinea pigs and monkeys with the causative agent. , 1968, British journal of experimental pathology.

[31]  G. Korb,et al.  [Pathological anatomy of the "Marburg virus" disease (the so-called "Marburg monkey disease")]. , 1968, Deutsche medizinische Wochenschrift.

[32]  R. Siegert,et al.  [Isolation and identification of the "Marburg virus"]. , 1968, Deutsche Medizinische Wochenschrift.